- Home
- CTRE vs VRNA Comparison
CTRE vs VRNA Comparison
Compare CTRE & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRE
- VRNA
- Stock Information
- Founded
- CTRE 2013
- VRNA 2005
- Country
- CTRE United States
- VRNA United Kingdom
- Employees
- CTRE N/A
- VRNA N/A
- Industry
- CTRE Real Estate Investment Trusts
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- CTRE Real Estate
- VRNA Health Care
- Exchange
- CTRE Nasdaq
- VRNA Nasdaq
- Market Cap
- CTRE 7.5B
- VRNA 8.3B
- IPO Year
- CTRE N/A
- VRNA 2017
- Fundamental
- Price
- CTRE $34.19
- VRNA $106.43
- Analyst Decision
- CTRE Buy
- VRNA Buy
- Analyst Count
- CTRE 6
- VRNA 11
- Target Price
- CTRE $33.00
- VRNA $114.10
- AVG Volume (30 Days)
- CTRE 2.3M
- VRNA 1.3M
- Earning Date
- CTRE 10-28-2025
- VRNA 11-03-2025
- Dividend Yield
- CTRE 3.92%
- VRNA N/A
- EPS Growth
- CTRE 108.23
- VRNA N/A
- EPS
- CTRE 1.21
- VRNA N/A
- Revenue
- CTRE $373,415,000.00
- VRNA $221,673,000.00
- Revenue This Year
- CTRE $17.85
- VRNA $896.59
- Revenue Next Year
- CTRE $28.06
- VRNA $77.56
- P/E Ratio
- CTRE $28.30
- VRNA N/A
- Revenue Growth
- CTRE 50.83
- VRNA N/A
- 52 Week Low
- CTRE $24.79
- VRNA $27.54
- 52 Week High
- CTRE $34.92
- VRNA $106.45
- Technical
- Relative Strength Index (RSI)
- CTRE 58.23
- VRNA 73.36
- Support Level
- CTRE $33.61
- VRNA $106.15
- Resistance Level
- CTRE $34.60
- VRNA $106.42
- Average True Range (ATR)
- CTRE 0.56
- VRNA 0.20
- MACD
- CTRE -0.13
- VRNA -0.16
- Stochastic Oscillator
- CTRE 61.31
- VRNA 97.90
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.